Opioid withdrawal
Information
- Disease name
- Opioid withdrawal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03485430 | Active, not recruiting | N/A | Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up | March 22, 2018 | December 30, 2025 |
| NCT04470050 | Completed | Phase 1/Phase 2 | Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal | June 9, 2020 | February 18, 2021 |
| NCT02363998 | Completed | Phase 3 | Open-Label, Safety Study of Lofexidine | February 2015 | October 2015 |
| NCT02548728 | Completed | Phase 1/Phase 2 | Oxytocin Treatment of Opioid Dependence | February 2016 | December 2016 |
| NCT03017430 | Completed | Phase 4 | Pregabalin for Opiate Withdrawal Syndrome | January 2014 | December 2019 |
| NCT03174067 | Completed | Phase 4 | Buprenorphine in the Emergency Department | March 2013 | November 2016 |
| NCT03489161 | Completed | Early Phase 1 | Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal | August 1, 2018 | August 28, 2018 |
| NCT01262092 | Completed | Phase 2 | Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals | October 2010 | January 2012 |
| NCT03789214 | Completed | Phase 2 | Medical Management of Sleep Disturbance During Opioid Tapering | July 1, 2019 | June 10, 2021 |
| NCT01549652 | Completed | N/A | 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence | April 2011 | October 2016 |
| NCT04049799 | Completed | Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions | August 8, 2019 | February 1, 2024 | |
| NCT04075214 | Completed | N/A | Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal | November 19, 2019 | December 14, 2020 |
| NCT04080037 | Completed | N/A | Assessing Opioid Care Practices Using CPV Patient Simulation Modules | September 3, 2019 | October 29, 2019 |
| NCT04126083 | Completed | Phase 4 | Lofexidine for Adults Undergoing Lumbar Spine Surgery | September 1, 2019 | April 15, 2021 |
| NCT04140955 | Completed | N/A | Opioid Tapering After Spine Surgery | October 22, 2019 | December 8, 2020 |
| NCT04731935 | Completed | N/A | Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal | March 18, 2021 | May 26, 2021 |
| NCT04238754 | Completed | Phase 1/Phase 2 | Oral Cannabidiol for Opioid Withdrawal | November 1, 2020 | June 30, 2022 |
| NCT04218240 | Completed | Phase 2 | Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal | December 17, 2020 | March 23, 2023 |
| NCT06442566 | Not yet recruiting | Phase 1/Phase 2 | ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain | June 2024 | March 31, 2029 |
| NCT03813095 | Not yet recruiting | Phase 2 | Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction | October 2023 | December 2025 |
| NCT04325659 | Recruiting | Phase 2/Phase 3 | An Innovative Intervention for OUD Treatment | November 15, 2020 | October 30, 2025 |
| NCT05555485 | Recruiting | N/A | Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain | May 24, 2023 | September 30, 2027 |
| NCT05712707 | Recruiting | Phase 1/Phase 2 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | February 28, 2023 | April 30, 2025 |
| NCT05790551 | Recruiting | N/A | Suboxone Dispenser for OUD | March 2024 | August 2024 |
| NCT04759703 | Recruiting | Phase 2/Phase 3 | Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD | January 24, 2022 | June 1, 2025 |
| NCT05027919 | Recruiting | Phase 2 | Assessing a Clinically-meaningful Opioid Withdrawal Phenotype | February 1, 2022 | February 28, 2026 |
| NCT05053503 | Recruiting | N/A | Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder | May 25, 2022 | October 2024 |
| NCT05307458 | Recruiting | Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing | July 1, 2022 | December 31, 2024 | |
| NCT05511909 | Recruiting | Phase 2 | Evaluating Buspirone to Treat Opioid Withdrawal | December 15, 2022 | March 31, 2027 |
| NCT04162145 | Terminated | N/A | BRIDGE Device for Treatment of Opioid Withdrawal | November 15, 2019 | June 23, 2020 |
| NCT04740099 | Withdrawn | N/A | Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) | December 2021 | March 2023 |
| NCT03678792 | Withdrawn | Phase 3 | Comparison of Three Opioid Detoxification Treatment Regimens | November 15, 2019 | October 25, 2020 |